Cohance Lifesciences Limited has released its Integrated Annual Report for the financial year 2025-26. The report details the company’s performance, strategy, and outlook, emphasizing its commitment to advancing science, quality, safety, and responsibility. It covers key aspects of the business, including financial highlights, operational performance, and sustainability initiatives, providing stakeholders with a comprehensive view of the company’s progress and future plans.
Cohance Lifesciences Unveils FY 2025-26 Integrated Annual Report
Cohance Lifesciences Limited has officially released its Integrated Annual Report for the financial year 2025-26. This comprehensive document outlines the company’s strategic direction, operational performance, and sustainability efforts, underscoring its commitment to advancing science with quality, safety, and responsibility at its core.
Key Highlights from the Report
The report provides a detailed overview of Cohance Lifesciences’ business, segmented into Pharma CDMO, API+, and Speciality Chemicals verticals. It highlights the company’s focus on scientific differentiation, reliable execution, and fostering long-term customer partnerships. Financial performance for the year indicates consolidated revenue from operations of ₹2,268.6 Crore, with an adjusted EBITDA of ₹477.5 Crore. The company also emphasized its progress in expanding its capabilities in advanced therapeutic modalities such as ADCs and oligonucleotides, alongside its commitment to environmental stewardship and robust corporate governance.
Strategic Vision and Future Outlook
The Integrated Annual Report reflects Cohance Lifesciences’ strategy to leverage its scientific legacies and build a unified, science-led platform. Key priorities for the next phase of growth include strengthening the core business, scaling differentiated technologies, and deepening customer participation across development and commercial programs. The company also detailed its sustainability commitments, including targets for reducing emissions, water consumption, and waste generation, reinforcing its dedication to responsible business practices and long-term value creation for all stakeholders.
Source: BSE
